Table 4 Predictors of anemia in HIV Infected patients at 6 and 12Â months of HAART initiation at Zewditu Memorial Hospital, Addis Ababa, Ethiopia, 2012
Variable | 6Â months | 12Â months | ||
|---|---|---|---|---|
| Â | Crude OR (95% CI) | AOR (95% CI | Crude OR (95% CI) | AOR (95% CI |
Gender | Â | Â | Â | Â |
Female | 1.00 | 1.00 | 1.00 | 1.00 |
Male | 1.56 (1.16-2.11) | 1.59 (1.13-2.23) | 1.19 (0.84-1.68) | 1.01 (0.68-1.50) |
Age (in years) | Â | Â | Â | Â |
15-24 | 1.00 | 1.00 | 1.00 | 1.00 |
25-34 | 2.99 (1.17-7.69) | 3.50 (1.31-9.33) | 4.14 (1.26-13.55) | 5.92 (1.39-25.15) |
35-44 | 3.14 (1.22-8.09) | 3.09 (1.16-8.22) | 2.76 (0.83-9.15) | 3.27 (0.76-14.11) |
45-54 | 4.40 (1.65-11.73) | 4.32 (1.56-11.99) | 4.23 (1.23-14.52) | 4.78 (1.07-21.36) |
55+ | 4.07 (1.27-13.00) | 3.32 (0.99-11.16) | 2.99 (0.67-13.29) | 2.90 (0.48-17.54) |
CD4 count (cells/mm 3 ) | Â | Â | Â | Â |
≥350 | 1.00 | 1.00 | 1.00 | 1.00 |
200-350 | 1.11 (0.72-1.75) | 1.10 (0.69-1.75) | 2.07 (1.24-3.46) | 1.91 (1.13-3.25) |
0-199 | 1.29 (0.82-2.02) | 1.23 (0.76-1.99) | 2.31 (1.34-3.99) | 2.15 (1.21-3.82) |
Baseline anemia | Â | Â | Â | Â |
Not anemic | 1.00 | 1.00 | 1.00 | 1.00 |
Anemic | 2.64 (1.95-3.58) | 2.38 (1.71-3.33) | 1.74 (1.23-2.45) | 2.01(1.36-2.97) |
Medication history | Â | Â | Â | Â |
Prophylactic | Â | Â | Â | Â |
Co-trimoxazole | 0.81 (0.53-1.25) | 0.48 (0.17-1.32) | 0.68 (0.40-1.14) | 0.81 (0.32-2.11) |
Others | 0.83 (0.34-2.04) | 0.69 (0.27-1.76) | 0.28 (0.04-2.14) | 0.36 (0.05-2.78) |
Non-prophylactic | Â | Â | Â | Â |
Anti- TB drug | 1.69 (1.08-2.63) | 1.11 (0.68-1.82) | 2.08 (0.96-4.53) | 2.09 (0.90-4.83) |
HAART regimen | Â | Â | Â | Â |
d4T- based | 1.00 | 1.00 | 1.00 | 1.00 |
AZT- based | 0.88 (0.62-1.25) | 1.19 (0.81-1.76) | 1.15 (0.78-1.69) | 1.47 (0.96-2.26) |
TDF- based | 1.98 (1.30-3.03) | 2.87 (1.80-4.60) | 0.49 (0.26-0.94) | 0.80 (0.40-1.59) |